Preoperative anemia management in the coronavirus disease (COVID-19) era

Effects of Preoperative Intravenous Erythropoietin Plus Iron on Outcome in Anemic Patients After Cardiac Valve Replacement

Testing the Asymptomatic Pre-Surgical Population for Severe Acute Respiratory Syndrome Coronavirus 2

Blood Transfusions in Elective Cardiac Surgery: The Debate Continues

Cardiac Surgery-Enhanced Recovery Programs Modified for COVID-19: Key Steps to Preserve Resources, Manage Caseload Backlog, and Improve Patient Outcomes

Transatlantic Editorial: The Use of Multiple Arterial Grafts for Coronary Revascularization in Europe and North America

Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery: yes.

Coronary surgery in women: How can we improve outcomes.

Aprotinin revisited

A Systematic Review of Biocompatible Cardiopulmonary Bypass Circuits and Clinical Outcome

Cardiac Surgery in Australia During the COVID-19 Global Pandemic

Managing Fibrinolysis Without Aprotinin

Intraoperative Transesophageal Echocardiography During Coronary Artery Bypass Graft Surgery (CABG): A Major Step Toward Improving Outcomes in Cardiac Surgery

The clinical development of percutaneous heart valve technology: A position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI)

Perioperative Acute Kidney Injury

The rocky exhilarating journey from data to wisdom